Abstract
This survey aimed to estimate the prevalence of anti-Toxoplasma IgG and IgM antibodies in people living in north west Tuscany (central Italy) and to investigate the adherence to antenatal screening programs and access to the Toxo-test as well. Sera from a large sample of individuals suspected to have acute infection or from pregnant women (10,352 subjects) aged between 1 day and over 70 years were analysed for both IgG and IgM anti-Toxoplasma antibodies using an immunoenzymatic method or a chemo-luminescent immunoassay. Overall, the seroprevalence of IgG antibodies was 21.4% (95% CI 20.62–22.20). A positive trend according to age was found, with low positivity observed in younger age groups. Among women of reproductive age the prevalence of IgG antibodies was 19.4% (95% CI 18.64–20.26). The overall IgM seroprevalence was 1.07% (95% CI 0.87–1.27). A low IgM prevalence was also observed in women of reproductive age (0.8%; 95% CI 0.65–1.03). Our study seems to indicate that primary prevention is widespread among women. However, an epidemiological surveillance system for toxoplasmosis should be implemented, to assess the risk of congenital toxoplasmosis and to determine the true burden of disease in adults.
Similar content being viewed by others
References
Hill D, Dubey JP (2002) Toxoplasma gondii: transmission, diagnosis and prevention. Clin Microbiol Infect 8:634–640
Remington JS, McLeod R, Thulliez P, Desmonts G (2001) Toxoplasmosis. In: Remington JS, Klein J (eds) Infectious diseases of the fetus and newborn infant, 5th edn. Saunders, Philadelphia, pp 205–346
Wallon M, Kodjikian L, Binquet C, Garweg J, Fleury J, Quantin C, Peyron F (2004) Long-term ocular prognosis in 327 children with congenital toxoplasmosis. Pediatrics 113(6):1567–1572
Owen WE, Martins TB, Litwin CM, Roberts WL (2006) Performance characteristics of six Immulite 2000 TORCH assays. Am J Clin Pathol 126:900–905
Petersen E (2007) Toxoplasmosis. Semin Fetal Neonatal Med 12:214–223
Villena I, Ancelle T, Delmas C, Garcia P, Brézin AP, Thulliez P, Wallon M, King L, Goulet V (2010) Congenital toxoplasmosis in France in 2007: first results from a National surveillance system. Eur Surveill 15(25)pii: 19600
Montoya JG, Jordan R, Lingamneni S, Berry GJ, Remington JS (1997) Toxoplasmic myocarditis and polymyositis in patients with acute acquired toxoplasmosis diagnosed during life. Clin Infect Dis 24:676–683
Paspalaki PK, Mihailidou EP, Bitsori M, Tsagkaraki D, Mantzouranis E (2001) Polyomyositis and myocarditis associated with acquired toxoplasmosis in an immunocompetent girl. BMC Musculoskelet Disord 2:8
Contini C (2008) Clinical and diagnostic management of toxoplasmosis in the immunocompromised patient. Parassitologia 50(1–2):45–50
Hassene A, Vital A, Anghel A, Guez S, Series C (2008) Acute acquired toxoplasmosis presenting as polymyositis and chorioretinitis in immunocompetent patient. Jt Bone Spine 75(5):603–605
Klaeger AJ, Herbort CP (2009) Acute acquired toxoplasmic retinochoroiditis in a patient with anterior uveitis, amplified by immunosuppressive therapy. Int Ophthalmol 29(3):191–193
Neves Ede S, Kropf A, Bueno WF, Bonna IC, Curi AL, Amendoeira MR, Filho OF (2011) Disseminated toxoplasmosis: an atypical presentation in an immunocompetent patient. Trop Doct 41(1):59–60
Evengård B, Petersson K, Engman ML, Wiklund S, Ivarsson SA, Teär-Fahnehjelm K, Forsgren M, Gilbert R, Malm G (2001) Low incidence of Toxoplasma infection during pregnancy and in newborns in Sweden. Epidemiol Infect 127(1):121–127
Fan CK, Hung CC, Su KE, Chiou HY, Gil V, Ferreira Mda C, Tseng LF (2007) Seroprevalence of Toxoplasma gondii infection among inhabitants in the Democratic Republic of Sao Tome and Principe. Trans R Soc Trop Med Hyg 101(11):1157–1158
Bouhamdan SF, Bitar LK, Saghir HJ, Bayan A, Araj GF (2010) Seroprevalence of toxoplasma antibodies among individuals tested at hospitals and private laboratories in Beirut. J Med Liban 58(1):8–11
Hofhuis A, van Pelt W, van Duynhoven YT, Nijhuis CD, Mollema L, van der Klis FR, Havelaar AH, Kortbeek LM (2010) Decreased prevalence and age-specific risk factors for Toxoplasma gondii IgG antibodies in The Netherlands between 1995/1996 and 2006/2007. Epidemiol Infect 24:1–9
Jones JL, Kruszon-Moran D, Sanders-Lewis K, Wilson M (2007) Toxoplasma gondii infection in the United States, 1999 2004, decline from the prior decade. Am J Trop Med Hyg 77(3):405–410
Stricker R, Sitavanc R, Liassine N, de Marval F (2009) Toxoplasmosis during pregnancy and infancy. Swiss Med Wkly 139:643–644
De Paschale M, Agrappi C, Clerici P, Mirri P, Manco MT, Cavallari S, Viganò EF (2008) Seroprevalence and incidence of Toxoplasma gondii infection in the Legnano area of Italy. Clin Microbiol Infect 14(2):186–189
Bénard A, Petersen E, Salamon R, Chêne G, Salmi LR, European Toxo Prevention Study Group (EUROTOXO) (2008) Survey of European programmes for the epidemiological surveillance of congenital toxoplasmosis. Eur Surveill 13(15):1–13
Stagni L, Romano MA, Romano A, Magli A, Briganti F, Del Pezzo MA, Buffolano W (2009) Prenatal screening for congenital toxoplasmosis in Campania: preliminary report on activities and results. Mem Inst Oswaldo Cruz 104(2):374–377
Montoya JG, Liesenfeld O (2004) Toxoplasmosis. Lancet 363:1965–1976
ARS Toscana (2006) Nascere in Toscana – Anni 2002–2004. Documenti ARS 21: 140; www.arsanita.toscana.it
Petersen E, Vesco G, Villari S, Buffolano W (2010) What do we know about risk factors for infection in humans with Toxoplasma gondii and how can we prevent infections? Zoonoses Public Health 57:8–17
Valcavi PP, Natali A, Soliani L, Montali S, Dettori G, Chezzi C (1995) Prevalence of anti-Toxoplasma gondii antibodies in the population of the area of Parma (Italy). Eur J Epidemiol 11(3):333–337
Vezzo R, Vigorè L, Goglio A, Raglio A, Vecchia L, Terenziani P, Fortina G et al (2001) Sieroprevalenza per anticorpi anti-Toxoplasma gondii in 14.186 soggetti. Microbiol Med 16:220
De Paschale M, Agrappi C, Clerici P, Mirri P, Manco MT, Cavallari S, Viganò EF (2006) Prevalence of Toxoplasma gondii infection in the Italian and foreign female population living in the area of Legnano (Milan). Microbiol Med 21:322–327
Condorelli F, Scalia G, Stivala A, Costanzo MC, Adragna AD, Franceschino C, Santagati MG, Furneri PM, Marino A, Castro A (1993) Seroprevalence to some TORCH agents in a Sicilian female population of fertile age. Eur J Epidemiol 9:341–343
Castelli F, Tomasoni L, Caligaris S, Barberis D, Laddago V, Di Candilo F, Donato F (1995) Epidemiological aspects of congenital toxoplasmosis. Riv Parassitol 12:19–23
De Paschale M, Agrappi C, Manco MT, Cerulli T, Clerici P (2010) Implementation of screening for Toxoplasma gondii infection in pregnancy. J Clin Med Res 3:112–116
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Pinto, B., Castagna, B., Mattei, R. et al. Seroprevalence for toxoplasmosis in individuals living in North West Tuscany: access to Toxo-test in central Italy. Eur J Clin Microbiol Infect Dis 31, 1151–1156 (2012). https://doi.org/10.1007/s10096-011-1422-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10096-011-1422-8